EFFECTIVENESS OF INFLIXIMAB IN PATIENTS WITH JUVENILE ANKYLOSING SPONDYLARTHRITIS

The objective of open-labeled study was estimation of effectiveness and safety of infliximab — monoclonal antibodies to tumor necrosis factor (TNF) - in treatment of 48 patients with juvenile ankylosing spondylarthritis. Duration of observation was 6 weeks — 1,5 years. Anticytokine treatment was adm...

Full description

Bibliographic Details
Main Authors: A.L. Kozlova, E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, A.M. Chomakhidze, K.B. Isaeva, R.V. Denisova, E.Yu. Gudkova, A.O. Lisitsin
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2009-03-01
Series:Вопросы современной педиатрии
Online Access:https://vsp.spr-journal.ru/jour/article/view/1085

Similar Items